The effects of gabapentin, 400 mg and 800 mg, on anxiety induced by simulated public speaking (SPS) were investigated. Thirty-two normal male volunteers (aged 17-30 years) had their anxiety and mood evaluated by self-scales [Visual Analogue Mood Scale (VAMS) and Profile of Mood State (POMS)] during the SPS procedure. Physiological measures (heart rate and blood pressure) were taken. Treatment with gabapentin at 800 mg attenuated the anxiety of subjects that had a decrease on the VAMS item calm-excite. In addition, volunteers that received gabapentin at 400 mg and 800 mg showed a decrease in the hostility score in POMS. Our results suggest, in agreement with other studies, an anxiolytic potential to gabapentin.
Get full access to this article
View all access options for this article.
References
1.
Bond A J, Lader M H (1974) The use of analogue scales in rating subjective feelings . Br J Med Psychol47: 211-218
2.
Brown J P, Gee N S (1998). Cloning and deletion mutagenesis of the α2δ calcium channel subunit from porcine cerebral cortex . J Biol Chem273: 25458-25465
3.
Chouinard G, Beauclair L, Bélanger M C (1998). Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders . Can J Psychiatry43: 305-305
4.
de-Paris F, Busnello J V, Salgeuiro J B, Quevedo J, Izquierdo I, Kapczinski F (2000) The anticonvulsant compound gabapentin possesses anxiolytic but not amnesic effects in rats . Behav Pharmacol11: 169-173
5.
Erfurth A, Kammerer C, Grunze H, Normann C, Walden J (1998). An open label study of gabapentin in the treatment of acute mania . J Psychiatr Res32: 261-264
6.
Gee N S, Brown J P, Dissanayake V U K, Offord J, Thurlow R, Woodruff G N (1996). The novel anticonvulsant drug, gabapentin (neurontin), binds to the α2δ subunit of a calcium channel . J Biol Chem271: 5768-5776
7.
Ghaemi S N, Katzow J J, Desai S P, Goodwin F (1998) Gabapenin treatment of mood disorders: a preliminary study . J Clin Psychiatry59: 426-429
8.
Guimarães F S, Kohem C L, Gus G, Fillmann H S, de-Vecino M C A, de-Paoli C L, Ribeiro M A S (1989) A simple simulated public speaking test for evaluated anxiolytic drugs . Braz J Med Res22: 1083-1089
9.
Guimarães F S, Mbaya P S, Deakin J F W (1997) Ritanserin facilitates anxiety in a simulated public speaking . J Psychopharmacol11: 225-231
10.
Hetem L A B, de-Souza C J, Guimarães F S, Zuardi A W, Graeff F G (1993) D fenfluramine reduces anxiety induced by simulated public speaking . Braz J Med Res26: 971-974
11.
Honmou O, Oyelese A A, Koesis J D (1995). The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: a field potential analysis . Brain Res692: 273-277
12.
Kapczinski F, Curran H V, Gray J, Lader M (1994) Flumazenil has na anxiolytic effect in simulated stress . Psychopharmacology114: 187-189
13.
McNair D M, Frankenthaler L M, Czerlinsky T, White T W, Sasson S, Fischer S (1982) Simulated public speaking as a model of clinical anxiety . Psychopharmacology77: 7-10
14.
McNair D M, Lorr M, Droppleman L F (1988) Manual for the profile of mood states. Educational and Industril Testing Service, San Diego, CA
15.
Mellick G A, Mellicy L B, Mellick J D (1995). Gabapentin in the management of reflex sympathetic dystrophy . J Pain Sympt Man10: 265-266
16.
Monteiro-dos-Santos P C, Graeff F G, dos-Santos J E, Ribeiro R P P, Guimarães F S, Zuardi A W (2000) Effects of tryptophan depletion on anxiety induced by simulated public speaking . Braz J Med Res33: 581-587
17.
Pande A C, Polack M H, Crockatt J, Greiner M, Chouinard G, Lydiard R B, Taylor C B, Dager S R, Shiovitz T (2000) Placebo-Controled Study of gabapentin treatment of panic disorder . J Clin Psychopharmacol20: 467-471
18.
Pollack M H, Matthews J, Scott E L (1998) Gabapentin as a potential treatment for anxiety disorders . Am J Psychiatry155: 992-993
19.
Radulovic L L, Turck D, von Hodenberg A, Vollner K O, McNally W P, Dettart P D, Hanson B J, Bockbrader H N, Chang T (1995). Disposition of gabapentin (Neurontin) in mice, dogs, rats and monkeys . Drug Metab Dispos23: 441-448
20.
Ryback R, Ryback L (1995). Gabapentin for behavioral dyscontrol . Am J Psychiatry152: 1399-1399
21.
Schaffer C B, Schaffer L C (1997). Treatment of acute mania with gabapentin . Am J Psychiatry154: 291-292
22.
Singh L, Field M J, Ferris P, Hunter J C, Oles R J, Williams R G, Woodruff G N (1996). The antiepileptic agent gabapentin (Neurontin) possess anxiolytic-like and antinociceptive actions that are reversed by D-Serine . Psychopharmacology127: 1-9
23.
Stanton S P, Keck P E Jr, McElroy S L (1997) Treatment of acute mania with gabapentin . Am J Psychiatry154: 287-287
24.
Suman-Chauhan N, Webdale L, Hill D R, Woodruff G N (1993). Characterization of [3H]gabapentin binding to a novel site in the rat brain: homogenate binding studies . Eur J Pharmacol (Mol Pharmacol Sec)244: 293-301
